Guggenheim Has Lowered Expectations for ADC Therapeutics (NYSE:ADCT) Stock Price
ADC Therapeutics (NYSE:ADCT – Free Report) had its target price reduced by Guggenheim from $10.00 to $7.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities research analysts have also weighed in on ADCT. Stephens lifted their price objective on shares of ADC […]
ADC Therapeutics (NYSE:ADCT – Free Report) had its target price reduced by Guggenheim from $10.00 to $7.00 in a report published on Monday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities research analysts have also weighed in on ADCT. Stephens lifted their price objective on shares of ADC […]
